There is a need for effective medications to treat patients living with schizophrenia or bipolar I disorder (BD-I). LYBALVI®, combination of olanzapine and samidorphan, was recently approved the treatment adults BD-I. We estimated budgetary impact adding LYBALVI formulary from Commercial, Medicaid, Medicare perspectives in United States (US). A budget model (BIM) 3-year time horizon developed h...

BACKGROUND Multi-tier copayment designs in pharmacy benefit plans are intended to steer patients and prescribers to preferred drug therapies that have lower out-of-pocket costs for patients. OBJECTIVE To describe and assess physicians' prescribing experiences and opinions in a multi-tier, primarily 3-tier formulary environment in 2 Midwestern states. METHODS This was a cross-sectional surve...

BACKGROUND Managed care organizations use a variety of strategies to reduce the cost and improve the quality of medication use. The effectiveness of such policies is not well understood. The objective of this research was to update a previous systematic review of interventions, published between 1966 and 2001, to improve the quality and efficiency of medication use in the US managed care settin...

UNLABELLED Drug selection methods with scores have been developed and used worldwide for formulary purposes. These tools focus on the way in which the products are differentiated from each other within the same therapeutic class. Scoring Analytical Tool (SAT) is designed based on the same principle with score and is able to assist formulary committee members in evaluating drugs either to add or...